CannabizMD Webinars

Cannabis 2023 Legislative Landscape: Lessons Learned + Looking Forward

Published

8 months ago

May 11, 2024

2022 was a dynamic year for cannabis industry policy with significant action on both the federal and state levels. Three leading U.S. cannabis policy and law experts, Kay Doyle, Kristine Blackwood, and Lauren Niehaus, joined CannabizMD Founder/CEO Jacquie Cohen Roth on a webinar sharing their insights lessons on 2022 and how the cannabis industry will move forward in 2023. Collectively, the cannabis industry is operating in a unique regulatory framework with being federally illegal with U.S. states and territories leading the way as laboratories for creating sound policies and regulations.

President Joe Biden released the White House approach to federal marijuana (cannabis) reform in October 2022 and the first stand-alone cannabis bill became law in December 2022. New state medical cannabis programs came online and adult use was legalized in two states via ballot initiatives while three states’ legalization initiatives failed. The webinar discussion delivers tremendous insights on:

what’s best for the cannabis industry in terms of rescheduling or descheduling
the respective effect of both on the existing cannabis industry
the best DEA schedule for cannabis
the impact of the Marijuana and Cannabidiol Research Expansion Act
the cannabis industry champions for the 118th Congressional session
Congressional action on cannabis on SAFE banking
protections for patients in adult use markets
strategies for advocacy

Tune in the webinar recording via the link below.

Source link

Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

CannabizMD Webinars

Treating Grief + Medical Cannabis

Published

4 weeks ago

November 25, 2024

mscannabiz.com

Join medical cannabis experts for an insightful webinar delving into the therapeutic potential of medical cannabis in alleviating the complex spectrum of symptoms associated with grief.

Grief is the most complex of emotions. From shock and anguish to loneliness and depression, grieving individuals navigate a tumultuous emotional landscape. In this webinar, CannabizMD Founder/CEO Jacquie Cohen Roth, MS, will moderate a discussion with medical cannabis clinical experts exploring how specific cannabinoids and terpenes can target symptoms such as anxiety, PTSD, depression, intrusive thoughts, and depersonalization, offering a holistic approach to healing. The expert panel will discuss evidence-based strategies, dosage considerations, and the integration of cannabis into comprehensive grief support programs.

Don’t miss this opportunity to learn about innovative pathways toward emotional well-being during profound loss utilizing cannabinoid therapeutics.

Join us for an insightful webinar delving into the therapeutic potential of medical cannabis in alleviating the complex spectrum of symptoms associated with grief.

From shock and anguish to loneliness and depression, grieving individuals navigate a tumultuous emotional landscape. In this webinar, medical cannabis clinical experts will explore how specific cannabinoids and terpenes can target symptoms such as anxiety, intrusive thoughts, and depersonalization, offering a holistic approach to healing. Our expert panel will discuss evidence-based strategies, dosage considerations, and the integration of cannabis into comprehensive grief support programs.

Don’t miss this opportunity to learn about innovative pathways toward emotional well-being during profound loss. For an introduction to grief and the potential for treating its symptoms with medical cannabis, read “Treating Grief + Medical Cannabis,” authored by Jacquie Cohen Roth, MS.

Panel Members:

Jacquie Cohen Roth, MS (Moderator)

Evangelos Lintinis, M.D., MBA, Green Pillar Consulting, Educator, Researcher and Consultant

Tiffany Buckley, PharmD, BCPS, BCPP, Advanced Practice Psychiatric Pharmacist, Faculty in MS Medical Cannabis Science and Therapeutics, University of Maryland School of Pharmacy

Renee Reisinger, MSN, CRNP, MS, Cannabis Clinician, Adult/Women’s Health Primary Care Nurse Practioner

$30 Tickets on EventbriteA portion of the webinar’s net proceeds will support the following nonprofits:

NAMI

The Tea Pad Foundation LTD

The Elie Wiesel Foundation for Humanity

Source link

Author: mscannabiz.com

MScannaBIZ for all you Mississippi Cannabis News and Information.

CannabizMD Webinars

Hospice + Palliative Care: Medical Cannabis Complement or Alternative

Published

8 months ago

May 11, 2024

mscannabiz.com

Considered to be the model for quality, compassionate care for people facing a serious or life-limiting illness or injury, hospice care involves a team-oriented approach to expert medical care, pain management, and emotional and spiritual support expressly tailored to the patient’s needs and wishes. Patients with life-ending and shortening diseases suffer symptoms of chronic pain, nausea, and anorexia. Evidence continues to evolve regarding the role of medical cannabis to treat these symptoms and improving the quality of life for hospice and palliative care patients. .

Unfortunately, patients and their caregivers are receiving little information or support from healthcare providers regarding the increasingly widespread use of medical cannabis or, cannabinoid-based medicines (CBM) for symptom relief. Providers are perplexed by the lack of available evidence-based research on CBM and the increased interest patients and their families have in CBM.

CannabizMD Founder/CEO Jacquie Cohen Roth, MS hosted the webinar “Hospice + Palliative Care: Medical Cannabis Complement or Alternative” with three hospice and palliative care healthcare providers: Nurse Toni, Dr. Jaclyn Schneider, M.D., and Dr. Blake Pearson. Despite diversity in their respective clinical practice and geographic location, they share a commitment to the therapeutic benefits of medical cannabis for their patients. The ensuing conversation goes beyond hospice and palliative care to treating veterans and community members’ PTSD with medical cannabis; medical cannabis in the Canadian healthcare system; dosing standards; the challenges of polypharmacy, and how to overcome the stigma held by provider colleagues.